project id: TCGA-LUAD; case submitter id: TCGA-80-5611; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 2595.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8230/3; primary diagnosis: Solid carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.2; oct embedded: No; shortest dimension: 0.6; portion submitter id: TCGA-80-5611-01A-01; percent necrosis: 10.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 80.0;